• Rheonix Adapts and Innovates to Aid COVID-19 Response in Eastern Finger Lakes

    Last fall, high-tech diagnostics maker Rheonix applied to the Food and Drug Administration for clearance of its molecular test for certain transmissible infections. It would have been the Lansing-based company’s first foray into the clinical market. Then COVID-19 hit and Rheonix faced an uncertain timeline for FDA approval. Read more »